Our present results indicated that inulin oligosaccharide effectively ameliorate DSS-induced colitis, as evidenced by a normal mucosal lining, a lesser body weight loss, lower expressions of pro-inflammatory cytokines and a higher expression of IL-10 compared with the respective level in the DSS group. The gene discussed is IL10; the disease is colitis.